Skip to main content
HR 1750 119th Congress House Health

HEARD Act of 2025

Introduced: February 27, 2025 Introduced by: Strickland, Marilyn Democratic · Washington See on congress.gov
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 27, 2025
Introduced in House
Feb 27, 2025
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Natural Resources, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
 Votes taken on this bill 1
DateChamberWhat was voted onResultYes–No
Apr 13, 1989 Senate · vote #44 On Passage of the Bill H.R. 1750 Passed 899 See who voted →
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Health Equity and Rare Disease Act of 2025 or the HEARD Act of 2025

This bill establishes Department of Health and Human Services (HHS) grants and other initiatives to address rare diseases or conditions (e.g., those affecting less than 200,000 people in the United States) in racial and ethnic minority populations. 

For example, to advance such purposes, the bill establishes within HHS

  • grants to public and private nonprofit entities for data collection and public outreach,
  • grants to health professions schools to improve health care and minority representation in research regarding rare diseases and conditions,
  • grants to tribal epidemiology centers and tribal and urban Indian health centers for research regarding rare diseases and conditions in tribal communities,
  • scholarships and educational loan repayment for medical school students who agree to work as health care professionals serving populations with rare diseases or conditions,
  • initiatives to coordinate research and other activities across the National Institutes of Health, and
  • public health awareness and education campaigns.

Also, the bill requires HHS to submit various reports to Congress on topics including (1) the federal government’s research and public health activities regarding rare diseases or conditions in minority populations, (2) regulatory barriers to treating rare diseases in Medicare beneficiaries of color, and (3) strategies for research and development of treatments for rare diseases or conditions that disproportionately impact minority populations.

What's happening now February 27, 2025

Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Natural Resources, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 3
 Lobbying activity 2

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

  • HOLLAND & KNIGHT LLP
    for BLACK WOMEN'S HEALTH IMPERATIVE · Georgia · 1st Quarter (Jan 1 - Mar 31) 2026
  • HOLLAND & KNIGHT LLP
    for BLACK WOMEN'S HEALTH IMPERATIVE · Georgia · 4th Quarter (Oct 1 - Dec 31) 2025
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 1750: HEARD Act of 2025. 119th Congress. Open America. https://openamerica.io/bill/119-HR-1750/
MLA
"H.R. 1750: HEARD Act of 2025." 119th Congress, 2026, Open America, https://openamerica.io/bill/119-HR-1750/.
Bluebook (legal)
H.R. 1750, 119th Cong. (2026), https://openamerica.io/bill/119-HR-1750/.
Markdown link
[H.R. 1750: HEARD Act of 2025](https://openamerica.io/bill/119-HR-1750/)
Report a problem